Notícias Eulerpool Innovent Biologics

Innovent Biologics Notícias de ações

Innovent Biologics é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Innovent Biologics nós reunimos aqui.

• 17 de janeiro ·

  Yahoo
  CDE grants BTD to Innovent’s IBI343 for pancreatic cancer
• 17 de janeiro ·

  Yahoo
  Innovent Presents at the 43rd Annual J.P. Morgan Healthcare Conference
• 8 de janeiro ·

  Yahoo
  High Growth Tech Stocks Innovent Biologics And 2 Other Promising Picks
• 3 de janeiro ·

  Yahoo
  Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration
• 2 de janeiro ·

  Yahoo
  Innovent and Roche link on lung cancer therapy development
• 2 de janeiro ·

  Yahoo
  Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate
• 27 de dezembro ·

  Yahoo
  Mankind Pharma and Innovent partner for Sintilimab commercialisation in India
• 20 de dezembro ·

  Yahoo
  Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
• 10 de dezembro ·

  Yahoo
  Exploring Three High Growth Tech Stocks For Potential Expansion
• 9 de dezembro ·

  Yahoo
  Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024